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Abstract
Background: Institutional Health Partnerships are long-term, institution to institution partnerships between high
income and low and middle income countries which seek to build capacity and strengthen health institutions in
order to improve health service delivery and outcomes. Funding for Institutional Health Partnerships has increased
in recent years. This paper outlines a rapid evidence review on the effectiveness of this modality.
Methods: A rapid evidence review of published and grey literature was conducted. Content relating to the
effectiveness of working in partnership and methods and frameworks used were extracted and analysed. The
results of this analysis were used to structure a discussion regarding the next steps to strengthen the evidence
base for the effectiveness of institutional health partnerships.
Results: The evidence review, including citation mapping, returned 27 published papers and 17 grey literature
documents that met all of the inclusion criteria. Most of the literature did not meet the high standards of formal
academic rigour and there was no original research amongst this literature that specifically addressed the effectiveness
of institutional health partnerships. This was not surprising given institutional health partnerships do not lend
themselves easily to case control studies and randomised control trials due to their high level of diversity and
operation in complex social systems. There was, however, a body of practice based knowledge and experience.
Conclusions: Evidence for the effectiveness of Institutional Health Partnerships is thin both in terms of quantity
and academic rigour. There is a need to better define and differentiate Institutional Health Partnerships in order
to measure and compare effectiveness across such a diverse group. Effectiveness needs to be measured at the
level of individual partnerships, the bodies that facilitate partnership programmes and the level of health service
delivery. There is a need to develop indicators and frameworks that specifically address the benefits and values
of partnership working and how these relate to effectiveness. These indicators need to be content neutral of
specific interventions which are already measured through routine project monitoring and evaluation. This
will allow the development of methodological pathways to assess the effectiveness of institutional health
partnerships. Until more primary research is conducted or published there is little benefit in further systematic
reviews.
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Introduction
This paper describes a rapid evidence review on the ef-
fectiveness of Institutional Health Partnerships (IHPs).
The focus is on the quality and quantity of evidence for
the effectiveness of IHPs and the methodological impli-
cations for future research. To the authors’ knowledge
no previous reviews have been conducted in this spe-
cific area.
Background
Efforts to strengthen health systems and attain better
health outcomes in low and middle income countries
(LMICs) are often hampered by health workforce issues
whereby health workers have limited access to high quality
education, mentoring support and continuing professional
development opportunities [1, 2]. Health partnerships be-
tween institutions in the “global north” and low and
middle-income countries (LMICs) seek to address this
challenge through long term institution-institution part-
nerships that typically focus on capacity building, clinical
service delivery and operational research. A central tenet
of institutional health partnerships (IHPs) is the provision
of long-term peer-peer support with the overall aim of
strengthening the health workforce and its institutions.
There is a long history of institutional health partner-
ship programmes between southern partners and those
from Europe, North America and Canada. Working in
partnership is now an established approach for North–
south cooperation and achieving global health and de-
velopment goals [3]. The Sustainable Development
Goals (SDGs) give continued attention to North–South
partnerships as a means of capacity building. In recent
years there has been a renewed interest from govern-
ments, donors and other stakeholders in the potential
opportunities and benefits that IHP programmes bring
[4]. WHO recognises the contribution of institutional
partnerships to health systems strengthening through
“peer reviews, exchange visits, communities of practice,
travelling seminars and institutional twinning” [5]. The
Global Catalyst Group for Institutional Health Partner-
ships [3] was established in 2014 by WHO and other
IHP programmes to promote the utility of institutional
health partnerships in strengthening health systems and
in delivering effective health services1.
Investment in institutional health partnership pro-
grammes has increased over the last decade, however,
continued donor funding will necessitate establishing a
stronger evidence base for their effectiveness. Whilst
those who are engaged in partnership programmes be-
lieve that this approach is a valid, cost-effective and
complementary form of technical cooperation [6] it is
recognised that there is a lack of high quality evidence
and inherent difficulties in measuring the effectiveness
and benefits of partnership work [7]. To date, evaluations
and research have largely focused on assessing activities
and interventions of specific health partnerships rather
than evaluating the effectiveness of the health partnership
model, the added benefits of this approach or making
comparisons with other forms of technical cooperation.
Evidence is also needed about the role of IHPs within the
development cooperation landscape and the added value
of programmes dedicated to facilitating and supporting
IHPs. It is therefore important to the partnership commu-
nity to be able to demonstrate the effectiveness of IHPs
and distinguish their niche role in the current era where
funders and governments increasingly need to show
results.
This paper reports on a rapid evidence review of the ef-
fectiveness of IHPs commissioned by the European ES-
THER Alliance (EEA). The aim of this study was to
review published and unpublished literature on the effect-
iveness of IHPs. The authors’ also draw on experiences in
evaluating and facilitating IHP programmes as well as
managing and evaluating large-scale international tech-
nical assistance programmes.
Methods
A rapid evidence review of both peer-reviewed and grey
literature was conducted between December 2014 and
January 2015. Grey literature was included in this review
because there are few published research papers in this
area and unpublished documents and evaluations are
likely to contribute to this emerging field. Inclusion cri-
teria were agreed by the reviewers in consultation with
the EEA Evidence and Effectiveness Working Group (ex-
perts in the field of IHPs). Criteria for inclusion were
published or grey literature on IHPs where:
– the partnership is between northern and southern
institutions (single or multiple);
– the partnership extends beyond a single project;
– the partnership undertakes activities with a health
focus;
– the literature refers to effectiveness of partnership,
not just the activities and/or intervention.
The two reviewers jointly assessed initial results of
four articles to ensure consistent application of inclusion
criteria and analysis and then divided the literature
equally. Papers were only cross-checked when reviewers
had doubts in relation to applying the inclusion criteria
and/or analysis. Any disagreements were resolved by
negotiation.
Peer-reviewed literature
Two electronic databases were searched separately via
OVID.MEDLINE and Web of Science, using a standard
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set of search terms with no year limits. Three categories
separated by the Boolean operator “AND” were used:
1. Institutional health partnership (range of terms
including health link, health partnership, hospital
partnership, institutional partnership, paired
partnership, institutional health partnership, twinning
partnership, hospital twinning, collaborative link,
collaborative partnership, North–south partnership).
2. Geographical location (developing country, low
and middle income countries, Africa, Asia, Latin
America).
3. Effectiveness (range of terms including effective,
additional, benefit, evaluation, sustainability,
ownership, flexibility, mutual, frontline, peer, cost,
economic).
The titles and abstracts of all initial search results were
screened and all articles unrelated to institutional health
partnerships were excluded. All articles retained were then
screened again to determine that they met the agreed in-
clusion criteria.
Grey literature
The two reviewers were already familiar with much of
the grey literature having conducted several evaluations
of IHP programmes since 2012. European ESTHER
Alliance members also supplemented the grey literature
with documents relating to formal evaluations of indi-
vidual IHPs or partnership programmes as well as any
other documents identified as relating to effectiveness
of IHPs (eg unpublished research, think pieces, case
studies, conference presentations).
Final selection and citation mapping
Following collation of all documents that met the inclu-
sion criteria, and after removing all duplications, bibliog-
raphies were reviewed and references that were of
potential relevance were assessed against the inclusion
criteria.
Evidence assessment
All documents were assessed for the level of evidence
they provided. The traditional hierarchy of evidence
scoring was not used due to the limited amount of ori-
ginal research conducted in this field. IHPs often aim to
make improvements to institutions and their workforce
which are complex, change over time and are context
specific. These kinds of intervention do not lend them-
selves easily to the types of research that are at the top
of the evidence hierarchy such as randomised controlled
trials. Therefore an adapted scoring system [8] was used
to more easily distinguish between the evidence included
in this review.
Level 0: Expert opinion/advocacy.
Level 1: Coherent description of what was done and
with clear rationale (logical and convincing).
Level 2: Includes data that shows change, but
attribution not proven.
Level 3: Demonstrate causality through use of control
or comparison group.
Level 4: At least one replication studied independently
(shows repeatability).
Level 5: Systematic review.
Data analysis
The analysis of literature was “content neutral” with re-
spect to specific interventions, since these are rarely
comparable and specific educational, clinical, and man-
agement interventions are already well documented in
the international scientific literature. All published pa-
pers and short (<15 pages) grey literature documents
were scanned in their entirety. For longer documents
(mainly programme evaluations), initially the executive
summary was reviewed and then only relevant other
sections of the document. Short summaries were pro-
duced for each document reviewed and key data was
extracted.
Results
Quality and quantity of evidence
For the database searches (no year limits), MEDLINE
produced 49 hits and Web of Science 98 hits. After ex-
cluding those that did not meet inclusion criteria and
deleting duplicates, 18 published journal articles were
included from the initial database search. An additional
nine published articles were included after citation
searching and review of documents supplied by EEA
members.
The grey literature search returned a total of 42 docu-
ments. These were retrieved from the reviewer’s previ-
ous work on IHPs and supplied by EEA members from
Ireland, France, Germany, Norway and UK. After ex-
cluding those that did not meet inclusion criteria and
after deleting duplicates, a total of 17 grey literature
documents were included.
Therefore a total number of 44 published and grey lit-
erature documents were included in the review; of this
27 articles were from peer-reviewed literature and 17
from grey literature. Table 1 shows the number, type of
documents and level of evidence using the previously
cited assessment criteria.
The full list of papers reviewed and their level of evi-
dence categorisation is available in Additional file 1.
Excluding editorials, 63 % of the journal articles were
written by those directly involved in implementing the IHP.
Fifty-five per cent of journal articles and grey literature, ex-
cluding editorials, reported on multiple partnerships. Sixty-
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eight per cent of the literature reviewed was categorised as
Level 1 or Level 2 evidence. The literature at Level 0 (n =
10) showed an overarching support for the IHP approach
and a belief that this type of technical cooperation brings
a wide range of benefits to both northern and southern in-
stitutions and potentially strengthens health systems.
The literature at Levels 1 and 2 were case studies,
evaluations and research papers/reports. The case stud-
ies (n = 12) represent a valuable source of practice-based
knowledge with good descriptions of the process of im-
plementation but largely limited to activity and output
reporting. Whilst the Level 2 case studies report change
and present higher levels of analysis, the evidentiary
value on the effectiveness of IHPs is limited and attribu-
tion of change unproven. Case studies included a self-
reported outline of surgical capacity building in Uganda
which demonstrated long term effects through having a
robust baseline and subsequent collection and analysis
of indicators [9]. Corbin et al. [10] used the Bergen
Model of Collaborative Functioning (BMCF) to map the
successes and failures of one organisation’s North–south
partnership experience. Reflecting on a ten-year partner-
ship between the UK and Swaziland in public health,
Wright et al. [11] identify six principles behind their suc-
cess and report on quantified improvements in TB and
epilepsy indicators demonstrated through RCTs.
The evaluations (n = 10) were largely externally commis-
sioned and primarily reliant on secondary data supple-
mented with qualitative primary data. In general these
were comprehensive evaluations of IHP programmes with
clearly defined methodologies and greater depth and
quality of analysis, however, only half of the evaluations
reported the use of an evaluation framework. Paterson &
Telykov [12], Bouscharain & Moreau [13] and Doyle &
Kelly [6, 14] in evaluating partnership programmes all
used either the OECD/DAC evaluation criteria for devel-
opment programmes or a logic model framework. All
evaluations reviewed were rated at Level 2 in that the at-
tribution of change is not proven.
Of the seven research papers/reports reviewed all were
rated at Level 2, none of which specifically focused on
the effectiveness of the IHP approach. Several studies
looked at benefits of partnership working to the devel-
oped country partner through competency development
or reverse innovation. Smith et al. [15], Kiernan et al.
[16] and Longstaff [17] mapped skills gained through
international work onto NHS leadership and compe-
tency frameworks. Busse et al. [18] used the Association
of Schools and Programs of Public Health global health
competency framework. Hagen et al. [19] conducted a
phenomenological/hermeneutical study to look at the
development of cultural competence through exchange.
The three systematic reviews, categorised as Level 5,
recognised that the current standard of literature on
which their reviews were based did not meet the high
standards of formal academic rigour with little pub-
lished or unpublished literature on the specific area
they were reviewing in relation to IHPs. The particular
focus of the three systematic reviews were:
 Health outcomes (Smith [20]): concludes that
there is a lack of high quality research in this area
but that broad trends appear to demonstrate
improved health outcomes as a consequence of
health links.
 Reverse innovation (Syed et al. [21]): concludes that
benefits were largely soft (employee morale,
learning, better information sharing, personal
development, improved patient relationships). The
study did not find evidence for the broader ‘impact’
of these benefits on health systems.
 Benefits to UK partners (Jones et al. [22]):
concluded that there is little published or
unpublished literature on the impact of volunteering
and the existing evidence base was primarily
descriptive. The review identified six domains of
individual benefit to the UK and adapted them into
an existing framework (developed by Wales for
Africa) to show how the experience of overseas
volunteering could impact on individuals,
institutions and health care services.
There was no original research that specifically ad-
dressed the effectiveness of IHPs. A previous review of
partnerships across all sectors [23] identifies that there are
very few detailed and theoretically grounded case studies
of partnerships with most research based on secondary
data, questionnaire surveys or personal impressions.
The literature was also thin in terms of describing
methods, indicators and frameworks for measuring the
effectiveness of IHPs. The three systematic reviews iden-
tified an urgent need for more rigorous and standardised
methods and tools for reporting costs, benefits, effective-
ness, outcomes and impact of IHPs.
Discussion
Strengths and limitations of the review
This review is the first seeking to identify the quantity
and quality of evidence on the effectiveness of IHPs.
This is not a full systematic review, but we sought to use
Table 1 Level of evidence and type of document reviewed
Level 0 Level 1 Level 2 Level 3 Level 4 Level 5 Total
Grey
literature
2 1 14 0 0 0 17
Journal
article
8 6 10 0 0 3 27
Total 10 7 24 0 0 3 44
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the highest levels of rigour possible given the short time
frame available for the work. Robust methods were used
to review current grey and published literature. It is pos-
sible that key documents may have been missed due to
the more limited search strategy employed. Much of the
literature reviewed did not specifically evaluate the IHP
model, but alluded to the benefits and effectiveness of
using a partnership approach.
Main findings of the review
Overall the review identified the thinness of the evidence
base in terms of the quantity of studies and their loca-
tion at the lower end of the evidence scale. The vast ma-
jority (93 %) of the documents reviewed were Level 0, 1
or 2. These results are not surprising given that IHPs do
not lend themselves easily to case control studies and
randomised control trials [24], which sit at the top end
of the evidence hierarchy. IHPs seek to make improve-
ments to institutions and their workforce . These
changes are complex, evolve over time and are context
specific. In addition, attribution is notoriously difficult to
prove in settings with a myriad of partnerships and pro-
jects overlapping and interacting [7].
Limitations from the literature reviewed included;
small sample size, self-reported evaluations, lack of base-
lines and measurement of activities and outputs rather
than outcomes and impact. No studies used control
groups, comparison groups or tested for repeatability.
The need to develop rigorous and standardised methods
and tools for measuring the effectiveness of partnerships
was identified in the three systematic reviews and is also a
clear conclusion from this review.
There are, however, a number of conceptual questions
that need to be addressed before such frameworks and
methods can be developed. These relate to the definition
and differentiation of IHPs and defining what is meant by
effectiveness of IHPs. This discussion outlines these ques-
tions building on the analysis of the methods and frame-
works (or lack thereof) reviewed from the literature.
Implications for future monitoring and evaluation and
research
Definition and differentiation
The word partnership is both overused and misused.
Distinguishing IHPs from other forms of technical co-
operation is not necessarily straightforward. The major-
ity of documents did not provide a definition of IHPs.
The definitions provided in the systematic reviews are
broad descriptors of IHPs and do not clearly define their
specific and essential characteristics, see Table 2.
The various definitions have some common elements:
institution-to-institution partnerships, relationship be-
tween low income and high-income settings and capacity
development. Many of the IHP programme facilitators
have listed definitions on their websites or educational
materials. For example the Tropical Health and Education
Trust (THET) define IHPs in the UK as “long-term part-
nerships between UK health institutions and their counter-
parts in developing countries. Partnerships aim to improve
health services in developing countries through the recipro-
cal exchange of skills, knowledge and experience between
partners in the UK and those overseas” [25].
The ultimate aim of partnerships is variously defined as:
improving health outcomes; improving health service de-
livery; strengthening the health workforce and strengthen-
ing health systems. The documents reviewed and key
proponents of partnership working also identify a number
of benefits that arise from a value-led partnership ap-
proach and these often include: mutual benefit; local own-
ership; flexibility; access to frontline services; peer-to-peer
support and long-term commitment. Whilst there is a set
of values shared by the partnership movement they are
not exclusive to it. The multiplicity of aims, scale and
technical focus creates a challenge for creating a standard
framework or generic indicators that can be used to
measure and compare effectiveness and benefits of
working in partnership. This creates difficulties in
assessing effectiveness particularly in comparison to
other forms of technical cooperation.
A further layer of complexity is that health partnerships
operate at community, primary, secondary, tertiary and
national levels within the health sector. IHPs work within
single regions, single countries or across countries and
continents. The focus of IHPs varies from those with a
narrow technical or clinical focus to those with a broad in-
stitutional or health system remit. Partnerships also vary
by their stage of development from the first steps being
taken towards partnership to a maturity based on many
years collaboration. Hence when looking at effectiveness
there is an intrinsic problem of being able to compare like
with like within such a differentiated field. Defining and
differentiating institutional health partnerships in terms of
their scale, scope and purpose is a vital first step in being
able to develop methodological pathways for assessing the
effectiveness of partnerships beyond their own project log
frames.
What do we mean by effectiveness?
The Oxford English Dictionary defines effective as:
“powerful in effect; producing a notable effect”. The
OECD/DAC Evaluation Framework for Evaluating De-
velopment Assistance [26] defines effectiveness as: “a
measure of the extent to which an aid activity attains
its objectives.” Hence effectiveness needs to show mea-
sureable change against a specified objective. This is
not only at the level of individual partnerships, but as
Horton et al. [23] proposed in their analysis of
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partnership knowledge and practice, effectiveness
should be assessed at three levels:
 the level of individual partnerships;
 the level of organisations that facilitate and manage
a portfolio of partnerships;
 the level of health service delivery and systems.
The effectiveness of individual partnerships
The objectives of individual partnerships usually relate
to improving health service delivery within a specific in-
stitution or institutions and ultimately improving health
outcomes for users of those services. Partnerships that
are funded externally will usually require monitoring
and evaluation (M&E) of project outputs and where pos-
sible outcomes. However, partnerships typically have
modest resources and expertise to undertake M&E and
existing information systems within LMIC institutions
are often weak. Monitoring is often limited to quantify-
ing activities and outputs, such as number of personnel
trained or services provided, with improvements in qual-
ity of care or other outcomes rarely measured. The journal
articles relating to individual IHPs which were categorised
as Level 2 in this review go beyond measuring activities
and outputs but they are still relatively few in number (see
Additional file 1).
For similar reasons M&E rarely continues beyond the
envelope of project funding. This makes it difficult to as-
sess the effectiveness of partnerships in embedding and
sustaining changes within institutions. Ensuring sustain-
able change is notoriously difficult due to many health
system related factors including staff turnover, weak
supervision, supply chain problems and financial resour-
cing [27]. The fact that IHPs are built on a long-term
commitment implies that they should be able to sustain
change beyond project funding. Evidence of this would
be of key interest to donors and Ministries of Health
and would require monitoring and evaluation to occur
beyond the project-funding envelope.
Monitoring and evaluation in IHPs primarily focuses
on project outputs and outcomes and rarely measures
the process or additional benefits gained through work-
ing in partnership. There is increasing interest in the
partnership movement in defining what makes a quality
partnership; this is a move to focus on process as well as
the results of partnership activities. There are a number
of tools that have recently been developed to assess
adherence to quality of partnership standards [28, 29].
Currently, these quality of partnership standards are
based on practice-based knowledge and there is a lack of
an evidentiary base of how they relate to effectiveness. If
a partnership delivers successful change within an organ-
isation or service does that make it an effective partner-
ship? If a partnership is deemed to be high quality does
that mean that it is effective in delivering change within
organisations and services? Quality of partnership is
linked to the values that underpin the partnership
movement. Further work is needed to understand:
 how these values and standards relate to effectiveness;
 to what extent they are best practice in development
cooperation or reflect something specific to the
partnership model;
 and to what extent they link to some of the additional
benefits ascribed to working in partnership.
In this review a number of studies have been undertaken
to assess some of the additional benefits ascribed to part-
nership working. In particular, building professional com-
petencies in northern partner institutions was the topic of
some of the more methodologically robust studies in this
review [15–18].
Hence there are three levels at which individual health
partnership effectiveness is being assessed.
 The intervention or activities undertaken within the
partnership through monitoring and evaluation.
 The quality of the partnership through adherence to
principles or charters and increasingly through self-
assessment tools.
 The degree to which the partnership has delivered
additional benefits beyond the project log frame
Table 2 Definitions or descriptions of IHPs from the three systematic reviews included in this rapid review
Health links are long term partnerships between
UK health institutions and their counterparts in
developing countries. …. Links are typically
small partnerships that work in areas such as
capacity building or clinical service delivery.
Whereas some links are set up as small charities
with expenses covered by the individuals
involved, others are funded directly by the NHS.
Ultimately, one of the main objectives of health
links is to improve the health of the population
in the corresponding developing country.”
… international partnerships, … lead, stimulate,
and facilitate action on health challenges through
programming, advocacy and technical support.
…. Partners increasingly seek mutuality of
benefits, including two way flow of energies,
expertise and knowledge to justify investment.”
Partnerships to share learning and resources
between UK institutions and collaborators in Low
and Lower Middle Income Countries are one
model to improve health care delivery. It has
been proposed that such links promote genuine
understanding and respect for different societies
and cultures, offer a more sustainable, locally led
model of development, build capacity and
strengthen health systems in developing
countries.”
Smith [9] Syed et al. [1] Jones et al. [1]
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such as sustainability or mutual benefit, usually
through research studies.
At the first level it is almost impossible to compare IHPs
due to the diversity of objectives, activities and scale.
However, it should be possible to collate a set of indicators
based on research to look at both the quality of partner-
ship and additional benefits of working in partnership.
These indicators could be used consistently across a num-
ber of IHPs to build a better evidence base and conceptual
framework linking the partnership process to partnership
benefits. This would have the dual benefit of providing
evidence of the benefit of working in partnership and be-
ing able to distinguish effective from non-effective part-
nerships. These partnership indicators would complement
standard M&E that measures the effectiveness of activities
and interventions being delivered by the partnership. Pro-
viding robust evidence of partnership benefits and their
link to the partnership process would enable the partner-
ship movement to move from faith to science.
The effectiveness of organisations that facilitate and
manage a portfolio of institutional health partnerships
The effectiveness of IHPs is also influenced by the sup-
port and guidance provided by the body facilitating the
partnership (eg ESTHER national programmes, THET,
Wales for Africa and the American International Health
Alliance (AIHA)). In particular, the facilitating body may
assist partnerships in addressing knowledge and skills
gaps in relation to project management, development
cooperation, cultural competence and monitoring and
evaluation. The effectiveness of the facilitating body in
meeting these needs should have an impact on the ef-
fectiveness of the partnerships they facilitate.
Networking is a further benefit offered by the facilitat-
ing body. For example, the EEA connects its member
countries and the individual IHPs within their pro-
grammes, leading to opportunities for coordination and
collaboration at country and regional levels. Through
the EEA, links can be established with donors, WHO
and other organisations involved with IHPs. Implement-
ing partners are connected with national governments
and donor programmes within the countries. The net-
working approach facilitates scaling up of initiatives, as
seen in the spread strategy of the WHO African Partner-
ships for Patient Safety. These various aspects of net-
working provide additional support for IHPs through
information exchange, learning possibilities, joint activ-
ities (pooling funds), scaling up outcomes and possibil-
ities of additional funding.
Facilitating bodies and their partnership programmes
are usually regularly evaluated against the objectives set
with the donor for the overall programme of work. This
review included a number of evaluations of facilitating
bodies or partnership programmes: however, these fo-
cused on the effectiveness of implementation without
necessarily analysing the underlying strategy of the
programme. They also highlighted the varied scale and
technical focus of IHP programmes as well as the wide
range of approaches taken by facilitating bodies in pro-
viding support to IHPs.
The facilitating body, often with funders, sets the cri-
teria for providing funding to IHPs. This shapes the geo-
graphical and technical focus of funded partnerships,
their scale and quantity. Underlying this, often implicitly,
is a perspective on the role of IHPs within the array of
development cooperation modalities used by bilateral
donors. In most countries the amount of funding given
to IHPs is small in comparison to other funding in inter-
national health through multilateral agencies, technical
assistance and research.
There are three levels at which the effectiveness of the
facilitating bodies of partnerships programmes should be
assessed.
 Their effectiveness at providing guidance and support
to individual IHPs particularly in those areas which
may be outside their usual professional expertise.
 Their effectiveness at creating and strengthening
networks for coordination, collaboration and
funding at national and international levels.
 Their effectiveness at providing a portfolio of IHPs
that ultimately meets the donor objectives for this
mode of development cooperation.
This third aspect of effectiveness requires clarity of
the niche role of IHPs in the development cooperation
landscape to improve health service delivery and systems
in low and middle-income countries. In the literature
reviewed, none of the papers clearly identify the specific
niche role of IHPs within the wider international develop-
ment cooperation landscape.
The effectiveness of IHPs in improving health service
delivery and systems
There is also a lack of evidence of how IHPs are best uti-
lised within the wider development efforts to improve
health outcomes. There are a number of roles that have
been identified as being suited to IHPs:




 supporting frontline services;
 supporting clinical areas which traditionally do not
get much attention from donors eg epilepsy, non-
communicable diseases, surgery, mental health.
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The evaluation of the European ESTHER Alliance pro-
posed a differentiation of roles for IHP programmes (see
Fig. 1) within development cooperation dependent on
scale and technical focus [6]; with small-scale pro-
grammes being best suited for experimentation or incre-
mental learning. This implies that the facilitating body
needs to attach importance to dissemination of lesson
learning if the partnership programme is going to dem-
onstrate measurable change within a health service or
system. Large programmes with a narrow thematic focus
can take a programmatic approach similar to large
technical assistance programmes that are narrowly fo-
cussed. Large programmes with a wide thematic ap-
proach have the opportunity to work in any of these
ways or a combination of them; however there is a risk
that a scattergun approach will result in improvements
in individual institutions but without measureable
changes within the health system.
One of the challenges in looking at the effectiveness of
IHPs at the service delivery and system level is that of
scale and coverage. Only a small percentage of institu-
tions working in a thematic area may have partnerships.
Some IHPs have chosen to be strategic in their choice of
partner, linking to institutions that provide education
across a whole country or countries or linking to institu-
tions with national or regional reach. The WHO APPS
movement provides an example of how successful part-
nership initiatives can be encouraged to be taken up by a
wider movement. But for many institution-to-institution
partnerships, dissemination and scale up of successful in-
terventions is beyond the scope of their partnership activ-
ities. In order to be able to measure the effectiveness of
IHPs there needs to be clarity on how the work of individ-
ual IHPs working at an institutional level can impact
on health service s and the wider system. The literature is
increasingly showing that spread, scale up and dissemin-
ation do not happen unless they are planned and
resourced [30]. This continues to be an important consid-
eration for donors and facilitating bodies when designing
IHP programmes.
The scale and coverage of IHP portfolios also effects
their ability to adhere to the aid effectiveness agenda.
The partnership movement should continue to be based
on values of local ownership and alignment; however the
issues of fragmentation and harmonisation with other de-
velopment activities are challenging to the smaller scale
non-programmatic IHPs. For a beneficiary country Minis-
try of Health, it can be extremely challenging to keep track
of multiple partnerships and projects active within the
health sector, carrying the risk of losing out on good prac-
tice, lesson learning and the potential to go to scale. Facili-
tating bodies (and donors) have a potentially important
Fig. 1 Categorisation of partnership portfolios by scale and thematic focus [6]
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role in facilitating communication of best practice and les-
sons learned particularly with partner country govern-
ments. Best practices from technical cooperation
programmes would indicate that individual partnerships
should seek opportunities to link with other projects and
activities and build communication and dissemination
into their plans from the start. Measuring the effectiveness
of these vital spread and dissemination activities is
challenging.
Conclusion
Many modalities used within technical cooperation
between high income and low and middle income
countries lack a robust evidence base due to the meth-
odological difficulties inherent in comparing interven-
tions made within real world complex social systems.
Clinical interventions can and should be based upon
robust evidence at the top of the evidence hierarchy
such as randomised control trials. By contrast the
modality through which capacity and institutional
strengthening occurs within health systems and institu-
tions may need to build its evidence base using other
forms of robust methods from areas such as manage-
ment science, implementation science and social
science. Institutional Health Partnerships are being
increasingly promoted as a promising approach for
strengthening the health workforce and health systems.
However, evidence is currently thin and there are few
frameworks and indicators specific to the effectiveness
and benefits of working in partnership. Until further
primary research findings are published or concluded
there is little merit in conducting further systematic re-
views within the field due to the paucity of robust evi-
dence. A much needed first step is, therefore, building
a clear conceptual framework that defines and differen-
tiates IHPs and starts to build indicators and models
linking the values underpinning partnership working to
their benefits and effectiveness in institutional strength-
ening and capacity building along with identifying their
niche within the development cooperation field. This
paper proposes a number of levels at which effective-
ness of IHPs should be assessed: at the level of individ-
ual partnerships; at the facilitating body level; and
health service delivery or system levels. There are also
three facets important in assessing individual health
partnership effectiveness: the intervention or activities
undertaken within the partnership; the quality of the
partnership; and the degree to which the partnership
has delivered additional benefits beyond the project.
Each of these levels requires its own methodological
pathways focusing on measuring change, with an ultim-
ate goal of being able to undertake studies comparing
IHPs and the IHP modality to other forms of technical
cooperation.
Addendum
As identified in the limitations this was a rapid evidence
review. One paper that was not identified in the search
but would have been useful to the review was identified by
the peer reviewers of this paper. Rutter et al. [31] describes
a participatory process to develop an evaluation frame-
work for patient safety partnerships giving indicators not
only for the effectiveness of the patient safety interven-
tions but also partnership strength and national spread.
The indicators for partnership strength were based on
practice based knowledge and expert review and were not
validated. Indicators for national spread were activity
based. The framework Rutter et al. develop supports the
use of indicators to measure partnership effectiveness and
spread within health systems as well as intervention effect-
iveness and is a useful step forward in the development of
context appropriate evaluation frameworks.
Endnotes
1Members of Global Catalyst Group for institutional
health partnerships: WHO African Partnerships for Pa-
tient Safety, European ESTHER Alliance, International
Hospital Federation, THET, American College of Health
Care Executives
Additional file
Additional file 1: List of all literature included in the review
outlined in this paper. Includes a table listing the papers by level of
evidence and an additional table outlining additional benefits of
partnership cited in the papers. (DOCX 33 kb)
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
VD and EK designed the review, analysed the data and wrote the draft; DW
and YS conceptualised and commissioned the review and helped finalise the
paper. All authors read and approved the final manuscript.
Authors’ information
DW is the Programme Lead for the Global Health Programme at the Health
Service Executive in Ireland; he is Chair for the European ESTHER Alliance
and a member of the Evidence and Effectiveness Working Group of the
European ESTHER Alliance; he is also Chair of the Irish Forum for Global
Health.
YS is an Advisor for GIZ (The Deutsche Gesellschaft für Internationale
Zusammenarbeit GmbH), Germany she is Coordinator for ESTHER Germany.
She is a member of the Evidence and Effectiveness Working Group of the
European ESTHER Alliance.
VD is a Director of Capacity Development International and an Honorary
Lecturer for the Liverpool School of Tropical Medicine.
EK is a Director of Capacity Development International.
VD and EK have undertaken evaluations of individual institutional health
partnerships and of IHP programmes on behalf of THET and the European
ESTHER Alliance.
Acknowledgements
We would like to thank all the members of the Evidence and Effectiveness
Working Group of the European ESTHER Alliance and the Secretariat of the
European ESTHER Alliance for the fruitful discussions throughout and the
commissioning of this review.
Kelly et al. Globalization and Health  (2015) 11:48 Page 9 of 10
Author details
1Capacity Development International, Liverpool, UK. 2European ESTHER
Alliance, Paris, France. 3Forum for Global Health, Dublin, Ireland. 4GIZ (The
Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH), Berlin,
Germany.
Received: 8 May 2015 Accepted: 3 December 2015
References
1. Easterbrook PJ. Institutional partnerships in global health. Clin Med. 2011;
11(2):112–3.
2. Frenk J, Chen L, Bhutta ZA, Cohen J, Crisp N, Evans T, et al. Health
professionals for a new century: transforming education to strengthen
health systems in an interdependent world. Lancet. 2010;376(9756):1923–58.
3. Global Catalyst Group for Institutional Health Partnerships, Position
Statement, March 2014. http://www.who.int/patientsafety/implementation/
apps/global-catalyst-group.pdf?ua=1. Accessed 6.5.2015.
4. Crisp N. Global health partnerships: The UK contribution to health in
developing countries. London: Department of Health; 2007.
5. WHO. Health system strengthening, current trends and challenges. 2011.
WHA A64/13.
6. Doyle V, Kelly E. European ESTHER Alliance: Study. Evaluation Report, 2013.
Accessed 6.5.2015.
7. Smith C. The role of health links in international development: the need for
greater evidence? Trop Dr. 2012;42(2):65–6.
8. Puttick R, Ludlow J. Standards of Evidence for Impact Investing. London:
Nesta; 2012.
9. Haglund MM, Kiryabwire J, Parker S, Zomorodi A, MacLeod D, Shroeder R, et
al. Surgical capacity building in Uganda through twinning, technology, and
training camps. World J Surg. 2011;35(6):1175–82.
10. Corbin JH, Mittelmark MB, Lie GT. Mapping synergy and antagony in
North–south partnerships for health: a case study of the Tanzanian
women’s NGO KIWAKKUKI. Health Promot Int. 2013;28(1):51–60.
11. Wright J, Walley J, Philip A, Petros H, Ford H. Research into practice: 10 years
of international public health partnership between the UK and Swaziland.
Am J Public Health. 2010;32(2):277–82.
12. Paterson M, Telyukov A. Program Evaluation: AIHA Primary Healthcare
Partnerships in the Newly Independent States (1998–2006). 2007.
13. Bouscharain G, Moreau J-B. Evaluation of the Institutional Twinning
Instrument in the Countries covered by the European Neighbourhood
Policy. Final Report HTSPE. 2012.
14. Doyle V, Kelly E. International Health Links Funding Scheme Evaluation on
behalf of THET, Capacity Development International. 2012. http://www.thet.
org/hps/resources/evaluations-reports/ihlfs-full-evaluation-report. Accessed
6.5.2015.
15. Smith C, Pettigrew L, Seo H-N, Dorward J. Combining general practice with
international work: online survey of experiences of UK GPs. JRSM Short Rep.
2012;3(7):46.
16. Kiernan P, O’Dempsey T, Kwalombota K, Elliott L, Cowan L. Evaluation of
effect on skills of GP trainees taking time out of programme (OOP) in
developing countries. Educ Prim Care. 2014;25:78–83.
17. Longstaff B. Innovative Workforce Development: the case for international
health links, North East Strategic Health Authority. 2010.
18. Busse H, Aboneh E, Tefera G. Learning from developing countries in
strengthening health systems: an evaluation of personal and professional
impact among global health volunteers at Addis Ababa University’s Tikur
Anbessa Specialized Hospital (Ethiopia). Glob Health. 2014;10(1):64.
19. Hagen L, Munkhondya B, Myhre K. Similarities and mutual understanding:
exchange experiences in Malawi for host and guest students. Int Nurs Rev.
2009;56(4):476–82.
20. Smith C. Do UK health links improve health outcomes? Alma Mata J Global
Health, 2013, 3 (1).
21. Syed SB, Dadwal V, Rutter P, Storr J, Hightower JD, Gooden R, et al.
Developed-developing country partnerships: benefits to developed
countries? Glob Health. 2012;8:17.
22. Jones FA, Knights DPH, Sinclair VFE, Baraitser P. Do health partnerships with
organisations in lower income countries benefit the UK partner? A review of
the literature. Glob Health. 2013;9(1):38.
23. Horton D, Prain G, Thiele G. Perspectives on partnership: A literature review.
Lima: International Potato Center (CIP); 2009. p. 122 [Social Sciences
Working Paper No. 2009–3].
24. Ritman D, Zegeye H. The value of health partnerships: a practical approach
to evidence. Trop Dr. 2012;42(October):241–2.
25. http://www.thet.org/health-partnership-scheme/resources/tools-guidance/
how-to-start-a-health-partnership Accessed 6.5.2015
26. OECD/DAC Criteria for Evaluating Development Assistance. http://www.
oecd.org/dac/evaluation/49756382.pdf Accessed 6.5.2015
27. WHO. Everybody business: strengthening health systems to improve
health outcomes: WHO’s framework for action. Geneva: World Health
Organisation; 2007.
28. EEA Quality of Partnership Charter, http://www.esther.eu/key_document/
esther-charter. Accessed 6.05.2015
29. WHO APPS Principles of Partnership, http://www.who.int/patientsafety/
implementation/apps/resources/detailed-resources/en/ Accessed 6.05.2015
30. Massoud MR, Mensah-Abrampah N, Barker P, Leatherman S, Kelley E, Agins
B, et al. Improving the delivery of safe and effective healthcare in low and
middle income countries. BMJ. 2012;981:1–2.
31. Rutter P, Syed SB, Storr J, Hightower JD, Bagheri-Nejad S, Kelley E, et al.
Development of an evaluation framework for African-European hospital
patient safety partnerships. BMJ Qual Safety. 2014;23:332–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Kelly et al. Globalization and Health  (2015) 11:48 Page 10 of 10
